Background The patent in question (EP 1173181) related to a new dosage regime for tadalafil (marketed under the brand name Cialis®) for treating erectile dysfunction (ED). The patent is owned by ICOS and exclusively licensed to Eli Lilly. The claims of the patent...
Background The Patent in question related to a method of producing platelet rich plasma (PRP) from whole blood. The inventive concept was said to reside in a resuspension step that allowed preparation of PRP from whole blood using only one centrifugation step. The...
The updated guidance note on Brexit and IP provided by the UKIPO makes it clear that the aim of the Government is still for Brexit to cause as little disruption as possible with respect to IP rights. However, despite a ‘no-deal’ Brexit being voted down earlier this...
Technetix was the proprietor of a patent for a cable tap, namely a unit which subdivides a cable TV signal arriving at a street cabinet to individual feeds for individual houses. Cable taps incorporate directional coupler units which reduce the strength of the cable...
Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
Introduction This case relates to a European patent (EP2269603) in the name of Novartis relating to derivatives of rapamycin. Claim 1 of the patent covers: “40-O-(2-hydroxyethyl)-rapamycin in combination with exemestane for use in the treatment of hormone...
Recent Comments